Literature DB >> 27531211

[Late-onset depression : Pathophysiology, diagnostics and treatment].

S Notzon1, J Alferink2, V Arolt2.   

Abstract

Late-onset depression (LOD) is defined as depression manifesting for the first time in later life. Up to now, there has been no exact definition of the lower age limit for LOD. Psychopathological symptoms of LOD do not fundamentally differ from depression in other phases of life; however, cognitive deficits are typically more pronounced. The LOD is associated with an increased risk of developing dementia. Imaging studies show reduction in gray matter volume and white matter lesions caused by vascular diseases. The occurrence of depression with vascular lesions of the brain is also referred to as "vascular depression". The diagnostic procedure includes a detailed medical history and the observation of psychopathological changes, physical examination, laboratory tests, electroencephalograph (EEG), electrocardiograph (ECG) and magnetic resonance imaging (MRI) of the head and neuropsychological tests to measure cognitive deficits. Psychotherapy is an effective treatment option. Selective serotonin reuptake inhibitors are the first-line pharmacological therapy.

Entities:  

Keywords:  Dementia; Electroconvulsive therapy; Lithium; Treatment resistance; Vascular depression

Mesh:

Substances:

Year:  2016        PMID: 27531211     DOI: 10.1007/s00115-016-0193-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  67 in total

1.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

2.  Older age is associated with rapid remission of depression after electroconvulsive therapy: a latent class growth analysis.

Authors:  Didi Rhebergen; Anne Huisman; Filip Bouckaert; King Kho; Rob Kok; Pascal Sienaert; Harm-Pieter Spaans; Max Stek
Journal:  Am J Geriatr Psychiatry       Date:  2014-05-14       Impact factor: 4.105

Review 3.  Diagnosis and treatment of depression and cognitive impairment in late life.

Authors:  Sarah Shizuko Morimoto; Dora Kanellopoulos; Kevin J Manning; George S Alexopoulos
Journal:  Ann N Y Acad Sci       Date:  2015-02-05       Impact factor: 5.691

4.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  Clinical effectiveness of integrating depression care management into medicare home health: the Depression CAREPATH Randomized trial.

Authors:  Martha L Bruce; Patrick J Raue; Catherine F Reilly; Rebecca L Greenberg; Barnett S Meyers; Samprit Banerjee; Yolonda R Pickett; Thomas F Sheeran; Angela Ghesquiere; Diane M Zukowski; Vianca H Rosas; Jeanne McLaughlin; Lori Pledger; Joan Doyle; Pamela Joachim; Andrew C Leon
Journal:  JAMA Intern Med       Date:  2015-01       Impact factor: 21.873

Review 6.  Origins of depression in later life.

Authors:  Dan G Blazer; Celia F Hybels
Journal:  Psychol Med       Date:  2005-09       Impact factor: 7.723

7.  Dysnomia in the differential diagnosis of major depression, depression-related cognitive dysfunction, and dementia.

Authors:  C D Hill; A Stoudemire; R Morris; D Martino-Saltzman; H R Markwalter; B J Lewison
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

Review 8.  Depression and Alzheimer's disease: neurobiological links and common pharmacological targets.

Authors:  Filippo Caraci; Agata Copani; Ferdinando Nicoletti; Filippo Drago
Journal:  Eur J Pharmacol       Date:  2009-10-18       Impact factor: 4.432

Review 9.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

Review 10.  HPA axis and aging in depression: systematic review and meta-analysis.

Authors:  Martino Belvederi Murri; Carmine Pariante; Valeria Mondelli; Mattia Masotti; Anna Rita Atti; Zefiro Mellacqua; Marco Antonioli; Lucio Ghio; Marco Menchetti; Stamatula Zanetidou; Marco Innamorati; Mario Amore
Journal:  Psychoneuroendocrinology       Date:  2013-12-17       Impact factor: 4.905

View more
  3 in total

Review 1.  [Psychotherapy of depressive disorders: Evidence in chronic depression and comorbidities].

Authors:  M Härter; A Jansen; M Berger; H Baumeister; T Bschor; T Harfst; M Hautzinger; L Kriston; C Kühner; H Schauenburg; S G Schorr; F Schneider; R Meister
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

Review 2.  [Diagnostics and multimodal treatment of depression in old age : New developments].

Authors:  Gerhard W Eschweiler
Journal:  Z Gerontol Geriatr       Date:  2017-01-19       Impact factor: 1.281

3.  Luteolin Enhances Choroid Plexus 5-MTHF Brain Transport to Promote Hippocampal Neurogenesis in LOD Rats.

Authors:  Hui-Zhen Li; Kai-Ge Liu; Ning-Xi Zeng; Xiao-Feng Wu; Wen-Jun Lu; Han-Fang Xu; Can Yan; Li-Li Wu
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.